
    
      The study duration for each patient is 28 weeks +/- 7 day broken down as follows:

        -  Screening phase: up to 2 weeks

        -  Run-in phase: 1 week

        -  Treatment phase: 24 weeks

        -  Follow-up: 1 week
    
  